Date set for FDA panel on drug-eluting stents
This article was originally published in Clinica
Executive Summary
The US FDA will announce tomorrow that it has scheduled an advisory panel meeting on December 7-8 to discuss recent studies that have shown a small, but significant, increase in the rate of death and heart attack due to blood clots linked to drug-eluting stents (DES).